Replimune Group Statistics
Total Valuation
Replimune Group has a market cap or net worth of $759.48 million. The enterprise value is $432.47 million.
Important Dates
The next estimated earnings date is Friday, November 7, 2025, before market open.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Replimune Group has 78.06 million shares outstanding. The number of shares has increased by 13.90% in one year.
| Current Share Class | 78.06M |
| Shares Outstanding | 78.06M |
| Shares Change (YoY) | +13.90% |
| Shares Change (QoQ) | +0.66% |
| Owned by Insiders (%) | 5.11% |
| Owned by Institutions (%) | 77.96% |
| Float | 49.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.25 |
| P/TBV Ratio | 2.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.94, with a Debt / Equity ratio of 0.23.
| Current Ratio | 6.94 |
| Quick Ratio | 6.80 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -36.94 |
Financial Efficiency
Return on equity (ROE) is -73.44% and return on invested capital (ROIC) is -40.00%.
| Return on Equity (ROE) | -73.44% |
| Return on Assets (ROA) | -36.45% |
| Return on Invested Capital (ROIC) | -40.00% |
| Return on Capital Employed (ROCE) | -71.46% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$585,006 |
| Employee Count | 479 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Replimune Group has paid $468,000 in taxes.
| Income Tax | 468,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.65% in the last 52 weeks. The beta is 0.42, so Replimune Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -19.65% |
| 50-Day Moving Average | 5.82 |
| 200-Day Moving Average | 8.71 |
| Relative Strength Index (RSI) | 70.64 |
| Average Volume (20 Days) | 8,742,467 |
Short Selling Information
The latest short interest is 18.25 million, so 23.38% of the outstanding shares have been sold short.
| Short Interest | 18.25M |
| Short Previous Month | 17.88M |
| Short % of Shares Out | 23.38% |
| Short % of Float | 36.51% |
| Short Ratio (days to cover) | 3.84 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -292.93M |
| Pretax Income | -279.75M |
| Net Income | -280.22M |
| EBITDA | -287.16M |
| EBIT | -292.93M |
| Earnings Per Share (EPS) | -$3.60 |
Full Income StatementBalance Sheet
The company has $403.34 million in cash and $76.33 million in debt, giving a net cash position of $327.01 million or $4.19 per share.
| Cash & Cash Equivalents | 403.34M |
| Total Debt | 76.33M |
| Net Cash | 327.01M |
| Net Cash Per Share | $4.19 |
| Equity (Book Value) | 336.72M |
| Book Value Per Share | 4.33 |
| Working Capital | 353.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$220.10 million and capital expenditures -$7.76 million, giving a free cash flow of -$227.86 million.
| Operating Cash Flow | -220.10M |
| Capital Expenditures | -7.76M |
| Free Cash Flow | -227.86M |
| FCF Per Share | -$2.92 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Replimune Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.90% |
| Shareholder Yield | -13.90% |
| Earnings Yield | -36.90% |
| FCF Yield | -30.00% |
Dividend DetailsAnalyst Forecast
The average price target for Replimune Group is $10.88, which is 11.82% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.88 |
| Price Target Difference | 11.82% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -34.88% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
